This product may not be available anymore.

Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk Details

  • The best price of Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk by Jumia in Egypt is 1,280 EGP
  • Available payment methods are
    Cash on DeliveryCredit CardE-Payment
  • Delivery fees are 15 EGP, with delivery expected within 2-5 day(s)
  • The first appearance of this product was on May 05, 2017

Technical Specifications

SKU:JU030BKAJ7AXNAFAMZ
Model:9780763769123
Author:Michael Klepper, Barton L Cobert

Jumia's Description

  • Format: Paperback
  • Number of Pages: 316 pages
  • Dimensions: 213.36 x 274.32 x 20.32mm
  • Weight: 748.42g
  • Publication date: 02 Nov 2010
  • Publisher: Jones and Bartlett Publishers, Inc

Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk was selected for The First Clinical Research Bookshelf - Essential reading for clinical research professionals by the Journal of Clinical Research Best Practices. Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk provides drug safety/pharmacovogilance professionals, pharmaceutical and clinical research scientists, statisticians, programmers, medical writers, and technicians with an accessible, practical framework for the analysis, summary and interpretation of drug safety data. The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for pre- and post-marketing risk assessment. With decades of pharmaceutical research and drug safety expertise, authors Dr. Klepper and Dr. Cobert discuss how quality planning, safety training, and data standardization result in significant cost, time, and resource savings. Through illustrative, step-by-step instruction, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is the definitive guide to drug safety data analysis and reporting. Key features include: * Step-by-step instruction on how to analyze, summarize and interpret safety data for mandatory governmental safety reports * Pragmatic tips...and mistakes to avoid * Simple explanations of what safety data are collected, and what the data mean * Practical approaches to determining a drug effect and understanding its clinical significance * Guidance for determining risk throughout the lifecycle of a drug, biologic or nutraceutical * Examples of user-friendly data displays that enhance safety signal identification * Ways to improve data quality and reduce the time, resources and costs involved in mandatory safety reporting * Relevant material for the required training of drug safety/pharmacovigilance professionals * SPECIAL FEATURE: Actual examples of an Integrated Analysis of Safety (IAS) -used in the preparation of the Integrated Summary of Safety (ISS) and the Summary of Clinical Safety (SCS) reports -, and the Periodic Safety Update Report (PSUR)

Top Products in Booksmore

    Reviews of Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk

    • No reviews exist yet for this product.

    Video Reviews of Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk

    • loading video reviews